Re: Genentech's Trastuzumab Emtansine (T-DM1) Reduces The Risk Of Cancer Worsening
Another synergy to be better explored is combining treatment modalities. Much points to the benefits (additive, synergy, or just not conflicting) of combining chemos, bios, hormonals and radiation. Yet most oncologists are taught to keep much of this separate..sequential. Part of the difficulty in exploring this is likely the inability to "own" the results, making costly trials hard to finance.
|